Aminoglycoside Resistance inPseudomonas aeruginosa

This publication has 188 references indexed in Scilit:

• The status of antimicrobial resistance in Taiwan among gram-negative pathogens: the Taiwan surveillance of antimicrobial resistance (TSAR) program, 2000
  Diagnostic Microbiology and Infectious Disease, 2004
• In Vitro Susceptibilities of Gram-Negative Bacteria Isolated from Hospitalized Patients in Four European Countries, Canada, and the United States in 2000-2001 to Expanded-Spectrum Cephalosporins and Comparator Antimicrobials: Implications for Therapy
  Antimicrobial Agents and Chemotherapy, 2003
• Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group
  Clinical Microbiology & Infection, 2003
• Inhaled Tobramycin (TOBI??)
  Drugs, 2003
• Geographic variations in activity of broad-spectrum β-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997–2000)
  Diagnostic Microbiology and Infectious Disease, 2002
• Aminoglycoside Resistance Mechanisms in Clinical Isolates of Pseudomonas aeruginosa from the Canary Islands
  Zentralblatt für Bakteriologie, 2000
• Incidence and mechanisms of aminoglycoside resistance inPseudomonas aeruginosa serotype O11 isolates
  Infection, 1995
• Mechanism of amikacin resistance in Pseudomonas aeruginosa isolates from patients with cystic fibrosis
  Diagnostic Microbiology and Infectious Disease, 1995
• Resistance to a minoglycosides in Pseudomonas
  Trends in Microbiology, 1994
• In vitro susceptibility to aminoglycoside antibiotics in blood and urine isolates consecutively collected in twenty-nine European laboratories
  European Journal of Clinical Microbiology & Infectious Diseases, 1987